RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Cyrcadia Asia, a Hong Kong medical device company, raised $3.8 million in a Pre-A round that was led by iFlytek. iFlytek is a prominent China AI/voice recognition company. Cyrcadia Asia is developing a wearable device that offers early diagnosis of breast cancer. The product, the iTBra™, consists of two patches worn in the bra for a minimum of two hours, once per month. The patches detect circadian temperature changes within breast tissue, and the readings are sent to the Cyrcadia Health lab for analysis.
Source: China Biotoday
